01 Jan
Health Food Expo, Ingredients and Contract Manufacture 2024 is approaching
On April 24th-25th 2024, Health Food Expo, Ingredients and Contract Manufacture 2024 will be held in Tokyo International Exhibition Hall, Japan. Dr Cheung, the chief scientist and founder of BONTAC, is invited to deliver a speech themed by Independent Wholechain Technology for Coenzyme Synthesis at this exhibition. BONTAC will display patent-grade raw materials for enzymes and natural products at Booth No. A15. See you there for more surprises!
About Dr. Cheung
Dr Cheung, the chief scientist and founder of BONTAC, was once engaged in research work at the Institute of Genetics and Developmental Biology in Chinese Academy of Sciences, Cornell University and City University of Hong Kong. She has been dedicated to the application of biological enzyme catalysis technology into the green bio-manufacturing industrialization of coenzymes, medical intermediates and natural products for over 20 years. Notably, Dr. Cheung has applied approximately 90 invention patents at home and abroad, authorized over 60 patents and conducted key R&D plan projects in Guangdong province as well as key science and technology projects in Shenzhen city.
BONTAC Product List
|
Niche Area
|
Products
|
Application Scope
|
|
Coenzyme
|
NMN (CAS No.: 1094-61-7)
|
Healthcare products; Cosmetics; Medicine
|
|
NAD (CAS No.: 53-84-9)
|
Healthcare products; Cosmetics; Diagnostic reagents
|
|
|
Raw materials for enzyme catalysis; Animal health
|
||
|
Endotoxin-free grade
|
||
|
NADH (CAS No.: 606-68-98)
|
Functional food and drink; Biomedical research and development
|
|
|
Healthcare product; Diagnostic reagents
|
||
|
NADP
(CAS No.: 24292-60-2/1184-16-3) |
Raw materials for medicine or enzyme catalysis; Diagnostic reagents;
|
|
|
In vitro diagnostic reagents (GR); Biomedical research and development
|
||
|
S-NAD (CAS No.: 4090-29-3)
|
Biochemical diagnostic reagents
|
|
|
NR (CAS No.: 23111-00-4)
|
Healthcare products; Cosmetics; Diagnostic reagent
|
|
|
Natural products
|
Ginsenoside Rh2
(CAS No.：78214-33-2) |
Healthcare products; Cosmetics; Drink; Alcohol; Medicine; Functional food
|
|
Ginsenoside Rg3
(Cas No. : 38243-03-7) |
||
|
Salidroside (Cas No.: 10338-51-9)
|
Healthcare products; Scientific research experiment; New drug development
|
|
|
Stevia Sweetener (RD)
(Cas No.: 63279-13-0 ) |
Food; Drink; Daily chemical industry; Brewing
|
|
|
Raw materials for cosmetics
|
Pro-Xylane
(CAS No.: 439685-79-7) |
Cosmetics
|
|
Erythrothioneine
|
Cosmetics
|
|
|
Dietary supplements
|
L-Glutathione Reduced
|
Healthcare products; Cosmetics
|
|
Resveratrol
|
Healthcare products; Cosmetics
|
|
|
Phosphatidylserine
|
Healthcare products; Biochemical diagnostic reagent
|
|
|
Medicine and intermediate
|
Ursodeoxycholic acid
(CAS No.: 128-13-2) |
Healthcare products; Biochemical diagnostic reagent
|
|
Chenodeoxycholic acid
|
Healthcare products; Biochemical diagnostic reagent
|
|
|
Cholic acid
|
Healthcare products; Biochemical diagnostic reagents
|
BONTAC profile
Bontac Bio-Engineering (Shenzhen) Co., Ltd. (also referred to as BONTAC) is a high-tech enterprise established in July 2012. BONTAC integrates R&D, production and sales. There are six major series of product in BONTAC, involving coenzymes, natural products, sugar substitutes, cosmetics, dietary supplements and medical intermediates. BONTAC is the pioneer of NMN industry. By virtue of the first whole-enzyme catalysis technology in China, BONTAC takes the industry lead in its niche field of coenzyme. Our coenzyme products are widely used in health industry, medical & beauty, green agriculture, biomedicine and other fields. BONTAC adheres to independent innovation, with more than 170 invention patents.
